Open Access
Issue
BioMedicine
Volume 9, Number 1, March 2019
Article Number 4
Number of page(s) 6
DOI https://doi.org/10.1051/bmdcn/2019090104
Published online 22 February 2019
  1. Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2017; 3: 524–48 [CrossRef] [PubMed] [Google Scholar]
  2. Berster JM, Goke B. Type 2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem. 2008; 114: 84–98 [CrossRef] [PubMed] [Google Scholar]
  3. Vasudevan AR, Balasubramanyam A. Thiazolidinediones: a review of their mechanisms of insulin sensitization, therapeutic potential, clinical efficacy, and tolerability. Diabetes Technol Ther. 2004; 6: 850–63 [CrossRef] [PubMed] [Google Scholar]
  4. Shimazaki N, Togashi N, Hanai M, Isoyama T, Wada K, Fujita T, et al. Anti-tumour activity of CS-7017, a selective peroxisome proliferator-activated receptor gamma agonist of thiazolidinedione class, in human tumour xenografts and a syngeneic tumour implant model. Eur J Cancer. 2008; 44: 1734–43 [CrossRef] [PubMed] [Google Scholar]
  5. Shen D, Deng C, Zhang M. Peroxisome proliferator-activated receptor gamma agonists inhibit the proliferation and invasion of human colon cancer cells. Postgrad Med J. 2007; 83: 414–9 [CrossRef] [PubMed] [Google Scholar]
  6. Grommes C, Karlo JC, Caprariello A, Blankenship D, Dechant A, Landreth GE. The PPARgamma agonist pioglitazone crosses the blood-brain barrier and reduces tumor growth in a human xenograft model. Cancer Chemother Pharmacol. 2013; 71: 929–36 [CrossRef] [PubMed] [Google Scholar]
  7. Lin HC, Hsu YT, Kachingwe BH, Hsu CY, Uang YS, Wang LH. Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study. J Clin Pharm Ther. 2014; 39: 354–60 [CrossRef] [PubMed] [Google Scholar]
  8. Bosetti C, Rosato V, Buniato D, Zambon A, La Vecchia C, Corrao G. Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis. Oncologist. 2013; 18: 148–56 [CrossRef] [PubMed] [Google Scholar]
  9. Govindarajan R, Ratnasinghe L, Simmons DL, Siegel ER, Midathada MV, Kim L, et al. Thiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes. J Clin Oncol. 2007; 25: 1476–81 [CrossRef] [PubMed] [Google Scholar]
  10. Ministry of Health and Welfare Taiwan. 2016 statistics of causes of death. http://www.mohw.gov.tw/EN/Ministry/Index.aspx. [cited on June 1, 2018, English version] [Google Scholar]
  11. Ministry of Health and Welfare Taiwan. 2016 Taiwan Health and Welfare Report. http://www.mohw.gov.tw. [cited on June 1, 2018, English version] [Google Scholar]
  12. Yang MD, Lin KC, Lu MC, Jeng LB, Hsiao CL, Yueh TC, et al. Contribution of matrix metalloproteinases-1 genotypes to gastric cancer susceptibility in Taiwan. Biomedicine-Taiwan. 2017; 7: 1824 [Google Scholar]
  13. Yang JS, Peng YR, Tsai SC, Tyan YS, Lu CC, Chiu HY. The molecular mechanism of contrast-induced nephropathy (CIN) and its link to in vitro studies on iodinated contrast media (CM). BioMedicine-Taiwan. 2018; 8: 1–11 [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  14. Pan CC, Huang HL, Chen MC, Kung CY, Kung PT, Chou WY, et al. Lower risk of end stage renal disease in diabetic nurse. Biomedicine-Taiwan. 2017; 7: 29–37 [Google Scholar]
  15. Chen YF, Wu KJ, Huang WS, Hsieh YW, Wang YW, Tsai HY, et al. Neuroprotection of Gueichih-Fuling-Wan on cerebral ischemia/ reperfusion injury in streptozotocin-induced hyperglycemic rats via the inhibition of the cellular apoptosis pathway and neuroinflammation. BioMedicine-Taiwan. 2016; 6: 15–23 [CrossRef] [PubMed] [Google Scholar]
  16. Wang X, Sheu JJ-C, Lai M-T, Chang C Y-Y, Sheng X, Wei L, et al. RSF-1 overexpression determines cancer progression and drug resistance in cervical cancer. BioMedicine-Taiwan. 2018; 8: 26–32 [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  17. Chen CM, Lai CH, Wu HJ, Wu LT. Genetic characteristic of class 1 integrons in proteus mirabilis isolates from urine samples. BioMedicine-Taiwan. 2017; 7: 12–7 [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  18. Wang IK, Lai SW, Lai HC, Lin CL, Yen TH, Chou CY, et al. Risk of and Fatality from Acute Pancreatitis in Long-Term Hemodialysis and Peritoneal Dialysis Patients. Perit Dial Int. 2018; 38: 30–6 [CrossRef] [PubMed] [Google Scholar]
  19. Lai SW, Liao KF, Liao CC, Muo CH, Liu CS, Sung FC. Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine. 2010; 89: 295–9 [CrossRef] [PubMed] [Google Scholar]
  20. Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lin CH. Nabumetone use and risk of acute pancreatitis in a case-control study. Pancreatology. 2016; 16: 353–7 [Google Scholar]
  21. Chu CS, Lin CC, Peng CY, Chuang PH, Su WP, Lai SW, et al. Does pyogenic liver abscess increase the risk of delayed-onset primary liver cancer?: Evidence from a nationwide cohort study. Medicine. 2017; 96: e7785 [CrossRef] [PubMed] [Google Scholar]
  22. Liao KF, Lai SW, Li CI. The impact of anti-diabetic drugs on colorectal cancer risk in a large cohort of women with diabetes. Libyan J Med. 2012; 7: 22 [Google Scholar]
  23. Lai SW, Liao KF, Lai HC, Muo CH, Sung FC. Individual Statins on the Risk of Colorectal Cancer: A Population-Based Observation in Taiwan. Kuwait Med J. 2012; 44: 255–6 [Google Scholar]
  24. Lin HF, Liao KF, Chang CM, Lin CL, Lai SW. Tamoxifen usage correlates with increased risk of Parkinson’s disease in older women with breast cancer: a case-control study in Taiwan. Eur J Clin Pharmacol. 2018; 74: 99–107 [CrossRef] [PubMed] [Google Scholar]
  25. Shen ML, Liao KF, Tsai SM, Lin CL, Lai SW. Herpes zoster correlates with pyogenic liver abscesses in Taiwan. BioMedicine-Taiwan. 2016; 6: 24–9 [CrossRef] [Google Scholar]
  26. Lin HF, Liao KF, Chang CM, Lin CL, Lai SW. Population-based cohort study examining the association between splenectomy and empyema in adults in Taiwan. BMJ Open. 2017; 7: e015101 [CrossRef] [PubMed] [Google Scholar]
  27. Lin HF, Liao KF, Chang CM, Lai SW, Tsai PY, Sung FC. AntiDiabetic Medication Reduces Risk of Pulmonary Tuberculosis in Diabetic Patients: A Population-based Cohort Study in Taiwan. Kuwait Med J. 2017; 49: 22–8 [Google Scholar]
  28. Cheng KC, Liao KF, Lin CL, Lai SW. Increased Risk of Pulmonary Tuberculosis in Patients with Depression: A Cohort Study in Taiwan. Front Psychiatry. 2017; 8: 235 [CrossRef] [PubMed] [Google Scholar]
  29. Liao K-F, Lin C-L, Lai S-W. Parkinson’s disease and risk of colorectal cancer: A population-based case-control study in Taiwan. Neurology Asia. 2017; 22: 133–8 [Google Scholar]
  30. Lai SW, Lin CH, Lin CL, Liao KF. Proton pump inhibitors therapy and the risk of hip fracture in older people in Taiwan. Eur Geriatr Med. 2018; 9: 169–74 [CrossRef] [Google Scholar]
  31. Hung SC, Liao KF, Hung HC, Lin CL, Lai SW, Lee PC, et al. Using proton pump inhibitors correlates with an increased risk of chronic kidney disease: a nationwide database-derived case-controlled study. Fam Pract. 2018; 35: 166–71 [CrossRef] [PubMed] [Google Scholar]
  32. Lin H-F, Liao K-F, Chang C-M, Lin C-L, Lai S-W. Statin use correlates with reduced risk of chronic osteomyelitis: a nationwide case- control study in Taiwan. Curr Med Res Opin. 2017; 33: 2235–40 [CrossRef] [PubMed] [Google Scholar]
  33. Lin HF, Liao KF, Chang CM, Lin CL, Lin CH, Lai SW. Use of thiazolidinediones and risk of hip fracture in old people in a case- control study in Taiwan. Medicine. 2017; 96: e7712 [CrossRef] [PubMed] [Google Scholar]
  34. Lin HF, Liao KF, Chang CM, Lin CL, Lai SW. Association of use of selective serotonin reuptake inhibitors with risk of acute pancreatitis: a case-control study in Taiwan. Eur J Clin Pharmacol. 2017; 73: 1615–21 [CrossRef] [PubMed] [Google Scholar]
  35. Lin HF, Liao KF, Chang CM, Lin CL, Lai SW. Correlation between proton pump inhibitors and risk of pyogenic liver abscess. Eur J Clin Pharmacol. 2017; 73: 1019–25 [CrossRef] [PubMed] [Google Scholar]
  36. Lin CM, Liao KF, Lin CL, Lai SW. Use of Simvastatin and Risk of Acute Pancreatitis: A Nationwide Case-Control Study in Taiwan. J Clin Pharmacol. 2017; 57: 918–23 [CrossRef] [PubMed] [Google Scholar]
  37. Hung SC, Lin CH, Hung HC, Lin CL, Lai SW. Use of Selective Serotonin Reuptake Inhibitors and Risk of Hip Fracture in the Elderly: A Case-Control Study in Taiwan. J Am Med Dir Assoc. 2017; 18: 350–4 [CrossRef] [PubMed] [Google Scholar]
  38. Hsu FG, Sheu MJ, Lin CL, Hsieh YW, Lai SW. Use of Zolpidem and Risk of Acute Pyelonephritis in Women: A Population-Based Case-Control Study in Taiwan. J Clin Pharmacol. 2017; 57: 376–81 [CrossRef] [PubMed] [Google Scholar]
  39. Lin HF, Liao KF, Chang CM, Lin CL, Lai SW. Tamoxifen usage correlates with increased risk of Parkinson’s disease in older women with breast cancer: a case-control study in Taiwan. Eur J Clin Pharmacol. 2018; 74: 99–107 [CrossRef] [PubMed] [Google Scholar]
  40. Cheng KC, Liao KF, Lin CL, Lai SW. Correlation of Proton Pump Inhibitors with Pulmonary Tuberculosis: A Case-Control Study in Taiwan. Front Pharmacol. 2017; 8: 481 [CrossRef] [PubMed] [Google Scholar]
  41. Okumura T. Mechanisms by which thiazolidinediones induce anticancer effects in cancers in digestive organs. J Gastroenterol. 2010; 45: 1097–102 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.